hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06327919 id: 62885 briefTitle: Effects of Probiotic Supplementation With Weight Reducing Plan in Patients With Food Addiction and Weight Regain After Bariatric Surgery overallStatus: COMPLETED date: 2022-06-01 date: 2023-05-25 date: 2023-09-23 date: 2024-03-25 date: 2024-03-25 name: National Nutrition and Food Technology Institute class: OTHER briefSummary: To study the effects of probiotic supplementation with a weight loss program and cognitive behavioral therapy (CBT) on anthropometric measures, eating behavior, food addiction, and related hormone levels in patients with food addiction and weight regain after bariatric surgery, 50 patients who referred to obesity clinic with weight regain (regaining ≥10% nadir weight) after bariatric surgery (at least 18 months), and food addiction will be randomly allocated to receive a weight loss program and CBT plus either probiotic, or placebo for 12 weeks. At the first and the end of the intervention, anthropometric measurements, eating behavior, food addiction, leptin, serotonin, and oxytocin will be assessed and compared between groups. conditions: Weight Regain After Bariatric Surgery and Food Addiction studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 50 type: ACTUAL name: Probiotic supplement name: Placebo supplement measure: Weight measure: BMI measure: Waist circumference measure: Fat mass measure: Food addiction measure: Eating behavior measure: Leptin measure: Serotonin measure: Oxytocin sex: ALL minimumAge: 18 Years maximumAge: 50 Years stdAges: ADULT facility: Azita Hekmatdoost city: Tehran state: Middle East zip: 19835 country: Iran, Islamic Republic of lat: 35.69439 lon: 51.42151 facility: National Nutrition and Food Technology Research Institute city: Tehran country: Iran, Islamic Republic of lat: 35.69439 lon: 51.42151 hasResults: False
nctId: NCT06327906 id: qilu000002 briefTitle: A Prospective Birth Cohort of Infants With Allergy and Neurodevelopmental Disorders in China overallStatus: RECRUITING date: 2023-11-15 date: 2026-11-15 date: 2029-11-15 date: 2024-03-25 date: 2024-03-25 name: Qilu Hospital of Shandong University class: OTHER briefSummary: In this study, a birth cohort was established to demonstrate the causal relationship between allergies and neurodevelopment disorders in infants and young children, and to find out the influencing factors of neurodevelopment disorders in early life. conditions: Child Allergy conditions: Neurodevelopmental Disorders studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 6000 type: ESTIMATED measure: ASD measure: ADHD sex: ALL minimumAge: 1 Minute maximumAge: 42 Days stdAges: CHILD facility: Qilu Hospital of Shandong University status: RECRUITING city: Jinan state: Shandong country: China name: zhu mengna role: CONTACT phone: 15211482407 lat: 36.66833 lon: 116.99722 hasResults: False
nctId: NCT06327893 id: AQUATIC_RESCUE briefTitle: Patients Treated by the Danish Emergency Medical Services Following Non-drowning Water Rescues From 2016 to 2023 acronym: RESCUE overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-05-01 date: 2025-05-01 date: 2024-03-25 date: 2024-03-25 name: Prehospital Center, Region Zealand class: OTHER briefSummary: Since 2015, all Danish prehospital EMS have used the nationwide Prehospital Electronic Medical Record (PEMR). In 2023, the investigators developed the Danish Drowning Formula (DDF), a text-search algorithm designed to search the unstructured text fields in the electronic medical records with comprehensive search criteria to identify all potential water-related incidents. This protocol describes the first study to analyse the prehospital data from a nationwide Danish cohort of patients treated by the EMS from 2016 to 2023 following non-drowning aquatic rescues. conditions: Drowning conditions: Drowning, Near conditions: Submersion conditions: Submersion - Accidental conditions: Submersion or Drowning Due to Being Washed Overboard conditions: Submersion or Drowning Due to Being Thrown Overboard conditions: Submersion or Drowning Due to Ship Sinking, Water Skier Injured conditions: Submersion or Drowning Due to Boat Submerging, Swimmer Injured conditions: Submersion or Drowning Due to Boat Overturning, Swimmer Injured conditions: Submersion or Drowning Due to Boat Submerging, Water Skier Injured conditions: Submersion or Drowning Due to Fall From Gangplank, Swimmer Injured conditions: Submersion or Drowning Due to Ship Sinking, Docker or Stevedore Injured conditions: Submersion or Drowning Due to Fall Overboard, Docker or Stevedore Injured studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 3000 type: ESTIMATED name: Submersion or immersion in liquid measure: The annual incidence. measure: The annual incidence rate. measure: The spatial distribution of aquatic rescues on a map of Denmark. sex: ALL stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Prehospital Center city: Næstved state: Region Zealand zip: 4700 country: Denmark lat: 55.22992 lon: 11.76092 hasResults: False
nctId: NCT06327880 id: C4151006 id: 2023-509339-17-00 type: REGISTRY domain: CTIS (EU) briefTitle: A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin overallStatus: NOT_YET_RECRUITING date: 2024-05-13 date: 2024-07-02 date: 2024-07-02 date: 2024-03-25 date: 2024-04-15 name: Pfizer class: INDUSTRY briefSummary: The purpose of this clinical study is to learn about the safety and effects of the study medicine (PF-07054894) in healthy Japanese participants.
In research, the participants in clinical studies are assigned by chance to separate groups that are given different treatments. Hence participants will be by chance assigned to receive either PF-07054894 or a harmless treatment that has no medical effect (placebo). Both these will be taken by mouth for 14 days. The total duration of the study is about 11 weeks, with a follow-up via telephone about 6 weeks after first treatment. conditions: Healthy studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: OTHER masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR count: 6 type: ESTIMATED name: PF-07054894 or placebo measure: Number of participants with adverse events (AE) or serious adverse events (SAE) measure: Number of participants with clinically meaningful change from baseline in laboratory tests results measure: Number of participants with clinically meaningful change from baseline in vital signs measure: Number of participants with clinically meaningful change from baseline in electrocardiogram (ECG) parameters measure: Maximal plasma concentration (Cmax) measure: Time to Maximum Plasma Concentration (Tmax) measure: Area Under the Plasma Concentration-Time Profile From Time Zero (AUCτ) To End of Dosing Interval (AUCt) measure: Half-life of PF-07054894 measure: Observed Accumulation Ratio (Rac) measure: Observed Accumulation Ratio Based on Cmax (Rac,Cmax) measure: Trough plasma concentrations (Ctrough) measure: Apparent Volume of Distribution (Vz/F) as data permits measure: Apparent Oral Clearance (CL/F) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Pfizer Clinical Research Unit - Brussels city: Brussels state: Bruxelles-capitale, Région DE zip: B-1070 country: Belgium lat: 50.85045 lon: 4.34878 hasResults: False
nctId: NCT06327867 id: drs2402021836 briefTitle: Comparison of Video Laryngoscopy Versus Direct Laryngoscopy for Orotracheal Intubation Among Adults in Emergency Department overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2025-03-01 date: 2025-05-01 date: 2024-03-25 date: 2024-04-11 name: Patan Academy of Health Sciences class: OTHER briefSummary: This is an open-label, single center, prospective, randomized, comparative, intervention study.
3. To compare the first pass success rate of DL vs VL according to demographic profile (age and sex) conditions: To Compare Success Rate of Video Laryngoscopy vs Direct Laryngoscopy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: An open-label, single center, prospective, randomized, comparative, intervention study. primaryPurpose: TREATMENT masking: NONE count: 126 type: ESTIMATED name: Oro Tracheal Intubation by DL name: Oro Tracheal Intubation by VL measure: First pass success of direct laryngoscopy in oro tracheal intubation measure: First pass success of video laryngoscopy in oro tracheal intubation measure: Complications rates between two methods. measure: Use of alternative methods for ventilation or oxygenation between two methods measure: Better visualization of Cormack-Lehane grading between two methods sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06327854 id: NUOROS (PI: M Briguglio) id: L4175 type: OTHER_GRANT domain: Italian Ministry of Health briefTitle: NUtrition and ORal Health in Orthopaedic Surgery overallStatus: RECRUITING date: 2024-03-18 date: 2024-03-22 date: 2024-12-10 date: 2024-03-25 date: 2024-03-25 name: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio class: OTHER briefSummary: This prospective observational study evaluates the relationship between the objective oral health status and the patient reported diet in 64 adult patients undergoing elective major orthopaedic surgery (hip, knee, or spine surgery). conditions: Orthopedic Disorder conditions: Metabolism and Nutrition Disorder studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 64 type: ESTIMATED measure: Association between pre-operative oral health and diet sex: ALL minimumAge: 55 Years stdAges: ADULT stdAges: OLDER_ADULT facility: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio status: RECRUITING city: Milan country: Italy name: Elena Cittera role: CONTACT phone: 00390283502224 email: elena.cittera@grupposandonato.it name: Matteo Briguglio role: PRINCIPAL_INVESTIGATOR lat: 45.46427 lon: 9.18951 hasResults: False
nctId: NCT06327841 id: EK 1117/2022 briefTitle: Plaque Reduction Sesame Oil overallStatus: COMPLETED date: 2022-06-21 date: 2022-08-18 date: 2022-08-18 date: 2024-03-25 date: 2024-03-25 name: Medical University Innsbruck class: OTHER briefSummary: The goal of this clinical trials to learn about potential additives in reducing dental plaque. The main questions it aims to answer is:
Researchers will compare sesame oil against distilled water to see if there is a difference in the plaque reducing effect. conditions: Dental Plaque conditions: Gingivitis conditions: Oral Microbial Colonization studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: DOUBLE whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 40 type: ACTUAL name: sesame oil name: distilled water measure: Rustogi Modified Navy Plaque Index (RMNPI) measure: Gingival Index (GI) measure: microbial analysis measure: Oral Health Impact Profile (OHIP) measure: Interview halitosis, xerostomia sex: ALL minimumAge: 18 Years maximumAge: 99 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Medical University city: Innsbruck state: Tyrol zip: 6020 country: Austria lat: 47.26266 lon: 11.39454 hasResults: False
nctId: NCT06327828 id: 32-663 briefTitle: Methimazole in Graves' Disease - a Randomised Controlled Trial Comparing the Computer-aided Treatment DigiThy Versus Usual Care overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2026-10-01 date: 2026-10-01 date: 2024-03-25 date: 2024-03-25 name: Medical University of Graz class: OTHER name: Graz University of Technology briefSummary: The goal of this clinical trial is to compare two methods of guiding methimazole therapy in patients with Graves' disease: methimazole dose adjustments based on a new semi-automated computer-guided treatment (based on a mathematical model) or based on the treating physician's decision (i.e. usual care). The main question it aims to answer is whether semi-automated computer-guided treatment is not inferior to usual care in terms of safety, the time it takes to achieve euthyroidism and the methimazole dose required. conditions: Graves Disease studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 52 type: ESTIMATED name: Semi-automated computer-aided treatment (Digital Thyroid, DigiThy) name: Usual care measure: The primary aim is to compare semi-automated computer-guided treatment with usual care in terms of their performance indices measure: Comparison in terms of dosing and penalties measure: Comparison based on free thyroxine (fT4) target range sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Medical University of Graz city: Graz zip: 8044 country: Austria name: Verena Theiler-Schwetz, MD, PhD role: CONTACT lat: 47.06667 lon: 15.45 hasResults: False
nctId: NCT06327815 id: D1690L00149 briefTitle: Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM overallStatus: RECRUITING date: 2024-03-27 date: 2025-04-30 date: 2025-04-30 date: 2024-03-25 date: 2024-04-15 name: AstraZeneca class: INDUSTRY briefSummary: Study D1690L00149 is a 24-week, multicentre, randomized, parallel, interventional, non-inferiority, open-label study designed to compare the FDC Regimen of Dapagliflozin/Metformin XR with the Dapagliflozin co-administered with Metformin XR in glycemic lowering control, satisfaction and adherence in Chinese patients with T2DM. conditions: Type 2 Diabetes Mellitus (T2DM) studyType: INTERVENTIONAL phases: PHASE4 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 632 type: ESTIMATED name: Xigduo (Dapagliflozin and Metformin hydrochloride extended-release) tablets name: Dapagliflozin tablets and Metformin HCl extended-release tablets measure: Change in HbA1c from baseline measure: Proportion of patients achieved HbA1c less than 7.0% from baseline to week 24. measure: Absolute change in FPG from baseline to week 24. measure: Absolute change in PPG from baseline to week 24. measure: The difference in satisfaction scores between 2 groups measured with the Diabetes Treatment Satisfaction Questionnaire (DTSQ) at week 24. measure: The difference in quality of life between 2 groups measured with Diabetes Quality of Life (DQOL) questionnaire at week 12 and week 24. measure: To evaluate the difference in adherence of FDC versus co-administered dual therapy by Morisky Medication Adherence Scale-8 (MMAS-8) questionnaire in Chinese patients with T2DM. measure: AEs measure: SAE measure: ADRs measure: Temperature measure: Systolic and diastolic BP measure: Pulse rate measure: Respiratory rate measure: Weight measure: Height measure: BMI measure: Number of participants with abnormal ECG readings measure: Proportion of TITR (Time in Tight Target Range) measure: TIR (Time In Range) measure: TBR (Time Below Range) measure: TAR (Time Above Range) measure: MAGE (Mean Amplitude of Glycemic Excursion) measure: SDBG (Standard Deviation of Blood Glucose) sex: ALL minimumAge: 18 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Research Site status: RECRUITING city: Beijing zip: 100020 country: China lat: 39.9075 lon: 116.39723 facility: Research Site status: NOT_YET_RECRUITING city: Wei Fang zip: 261035 country: China hasResults: False
nctId: NCT06327802 id: 20240104 briefTitle: Improving the Well-being of Caregivers of Cystic Fibrosis Patients During Physiotherapy Treatment acronym: MucoZar overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-12-31 date: 2025-07-31 date: 2024-03-25 date: 2024-03-25 name: Pole Sante Grace de Dieu class: OTHER briefSummary: The main objective of the study is to determine the impact of cystic fibrosis affecting a child on the parents' quality of life, their possible anxiety and depressive symptoms, their general fatigue and the feeling of burden in these caregivers. conditions: Cystic Fibrosis studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 360 type: ESTIMATED name: Questionnaire measure: Zarit Burden Interview sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: PSLA GDD city: Caen zip: 14000 country: France lat: 49.18585 lon: -0.35912 hasResults: False
nctId: NCT06327789 id: ZBEU-MS briefTitle: Trunk Control and Disability in Persons With Multiple Sclerosis overallStatus: COMPLETED date: 2021-12-21 date: 2021-12-25 date: 2022-02-21 date: 2024-03-25 date: 2024-03-25 name: Zonguldak Bulent Ecevit University class: OTHER briefSummary: This study aims to investigate the relationship between physical disability and trunk control, balance, and pedobarographic parameters in persons with Relapsing Remitting Multiple Sclerosis (RRMS) who have a low Expanded Disability Status Scale (EDSS) score. Twenty-three RRMS patients with an age range of 18-50 years, EDSS score ≤ 3 were included in this study. The patients' level of disability (EDSS), trunk control )Trunk Impairment Scale - TIS), lower extremity functionality (Timed 25-Foot Walk Test - T25FW), upper extremity functionality (Nine Hole Peg Test- 9HPT), balance (Biodex Balance System) and gait (Zebris® FDM 2) were evaluated. conditions: Multiple Sclerosis studyType: OBSERVATIONAL observationalModel: CASE_ONLY timePerspective: PROSPECTIVE count: 23 type: ACTUAL measure: Expanded Disability Status Scale (EDSS) measure: Trunk Impairment Scale (TIS) measure: Biodex Balance System (BBS) (MedicalSystems, Shirley, NY, USA) measure: Step Length (cm) measure: Stride Length (cm) measure: Step Width (cm) measure: Cadence (steps/min) measure: Velocity (m/s) measure: Step time (s) measure: Stride time (s) measure: Timed 25-Foot Walk Test (T25FW) measure: Nine-Hole Peg Test (9HPT) sex: ALL minimumAge: 18 Years maximumAge: 50 Years stdAges: ADULT facility: Zonguldak Bülent Ecevit University city: Zonguldak country: Turkey lat: 41.45139 lon: 31.79305 hasResults: False
nctId: NCT06327776 id: 21/709 briefTitle: New Protein Biomarkers and Technology for Improving Diagnosis and Outcome Prediction in Mild TBI overallStatus: RECRUITING date: 2022-03-04 date: 2025-07-31 date: 2025-12-31 date: 2024-03-25 date: 2024-03-25 name: Hospital Universitario 12 de Octubre class: OTHER briefSummary: Mild traumatic brain injury(mTBI) is a common cause of consultation to the emergency rooms worldwide and is the most common form of traumatic brain injury. Though classified as mild, as many as 40% of patients suffering mTBI do not make complete recoveries or present persistent symptoms. The present study is intended to determine long term outcome of patients suffering mTBI and to establish new prognostic models with the use of serum and saliva based biomarkers. For this purpose this study will not exclude patients regarding their comorbidities. conditions: Mild Traumatic Brain Injury studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 1000 type: ESTIMATED name: Serum and saliva biomarkers measure: Biomarkers diagnostic performance measure: Determination of the potential of the biomarkers in predicting neurological symptoms after TBI measure: Determination of the potential of the biomarkers in predicting neurological outcome assessed by the Extended Glasgow Outcome Score (GOSE) after TBI measure: Determination of the potential of the biomarkers in predicting quality of life assessed by Qolibri-OS after TBI measure: Determination of the potential of the biomarkers in predicting quality of life assessed by EQ-5D-5L after TBI measure: Determination of the potential of the biomarkers in predicting quality of sleep assessed by the Epworth and Pittsburgh Scales sex: ALL minimumAge: 15 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Hospital Universitario 12 de Octubre status: RECRUITING city: Madrid zip: 28041 country: Spain name: Alfonso Lagares, MD, PhD role: CONTACT phone: +34917792389 email: alfonso.lagares@salud.madrid.org lat: 40.4165 lon: -3.70256 hasResults: False
nctId: NCT06327763 id: Ilioinguinal Neurectomy briefTitle: Prophylactic Ilioinguinal Neurectomy During Open Tension-Free Inguinal Hernia Repair overallStatus: COMPLETED date: 2022-01-01 date: 2023-06-01 date: 2023-06-01 date: 2024-03-25 date: 2024-03-25 name: Zagazig University class: OTHER_GOV briefSummary: postoperative chronic inguinal pain is a common postoperative complication after open inguinal hernia repair.
Chronic inguinal pain is a common complication following open inguinal hernia repair. Ilioinguinal nerve entrapment is a common cause of this chronic pain which may adversely affect the patients' life. Ilioinguinal neurectomy seems to be beneficial in preventing such pain, but it carries the risk for numbness and hypoesthesia. conditions: Ilioinguinal Nerve Section conditions: Pain Prevention conditions: Hernioplasty studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: NONE count: 196 type: ACTUAL name: ilioinguinal nerve section measure: detect postoperative pain using short form inguinal pain questionnaire sex: MALE minimumAge: 16 Years maximumAge: 80 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: yasmine Hegab city: Zagazig zip: 7120730 country: Egypt lat: 30.58768 lon: 31.502 hasResults: False
nctId: NCT06327750 id: NL83566.018.24 briefTitle: The Microcirculation, Dialysis Modality and Sequestered Salt acronym: MIMOSA overallStatus: NOT_YET_RECRUITING date: 2024-06 date: 2027-12 date: 2027-12 date: 2024-03-25 date: 2024-03-25 name: Amsterdam UMC, location VUmc class: OTHER name: Dutch Kidney Foundation name: Niercentrum aan de Amstel name: B.Braun Avitum AG briefSummary: The aim of this clinical trial is to investigate the effect of 5 different dialysis treatments (combinations of dialysis mode and dialysis fluid sodium content) on the microcirculation (MC) and sequestered sodium content (SSC) in adult prevalent end-stage kidney disease (ESKD) patients treated with hemodialysis (HD) or hemodiafiltration (HDF). The main questions it aims to answer are:
This study is a randomized cross-over trial. Participants will be subjected to the abovementioned dialysis treatment modes in random order. conditions: End-stage Renal Disease studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER interventionModelDescription: Randomized cross-over trial primaryPurpose: TREATMENT masking: NONE count: 22 type: ESTIMATED name: Hemodialysis (DNa = PNa) name: Hemodialysis (DNa<PNa) name: Hemodialysis after isolated ultrafiltration (DNa=PNa) name: High volume hemodiafiltration (DNa=PNa) name: High volume hemodiafiltration (DNa<PNa) measure: Skin microcirculation measure: Sequestered salt content (SSC) measure: Intradialytic hypotension measure: Change in intradialytic blood pressure measure: Peridialytic blood pressure measure: Change in CK-MB measure: Change in high sensitivity C-reactive protein (hs-CRP) measure: Change in interleukin-6 receptor (IL-6R) measure: Change in soluble CD163 (sCD163) measure: Change in soluble intercellular adhesion molecule-1 (s-ICAM-1) measure: Change in serum glycosaminoglycans measure: Change in syndecan-1 measure: Change in vascular endothelial growth factor C (VEGF-C) measure: Change in extracellular vesicles (EVs) measure: Change in skin microcirculation measure: Change in sequestered salt content (SSC) measure: modified Dialysis symptom index (mDSI) measure: Thirst distress scale (TDS) measure: EQ Visual analogue scale (EQ VAS) sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False